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ABSTRACT 
The EFSA CEF Panel updated the safety assessment of the smoke flavouring Primary Product SmokEz Enviro 
23. In 2009, the Panel concluded that the margins of safety for this Primary Product were insufficient and the 
proposed use levels were considered of safety concern. After the opinion of 2009 the Panel received new data i.e. 
new use levels, chemical data and a new 90-day toxicity study, which resulted in this update of the previous 
opinion. The new chemical data provided demonstrate that the test material used in the new 90-day toxicity 
study is representative of the Primary Product evaluated by EFSA. Based on the findings from the 90-day study 
submitted in 2009 and from the newly submitted one, the Panel derived a NOAEL for Primary Product SmokEz 
Enviro 23 of 598 mg/kg bw/day based on absolute and relative kidney weight changes in female rats. Based on 
newly submitted normal use levels, the margins of safety are 62 and 77 (total dietary exposure) and 65 and 89 
(use in traditionally smoked foods only) depending on the exposure scenario used. Given that these margins of 
safety are based on 90-day toxicity studies, and given the absence of data on reproduction, developmental 
toxicity and of long term studies, it is concluded that the uses and use levels of Primary Product would require a 
larger margin of safety. The Panel concluded that the proposed use of the Primary Product at the uses and use 
levels specified is of safety concern. 
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SUMMARY 
Following a request from the European Commission (EC), the Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing aids (CEF), of the European Food Safety Autority (EFSA) re-
evaluated the safety of the smoke flavouring Primary Product SmokEz Enviro 23 based on new data 
(new use levels, chemical data and a new 90 day toxicity study) submitted by the applicant in 
accordance with Regulation (EC) No 2065/2003 of the European Parliament and the Council on 
smoke flavourings intended for use in or on foods. The other information required for the evaluation 
of the Primary Product SmokEz Enviro 23, in accordance with the Guidance document (EFSA, 2005), 
is available in the previous opinion published on 12 June 2009 (EFSA, 2009a). 
In the opinion published in 2009, the CEF Panel concluded that in the 90-day toxicity study with 
SmokEz Enviro 23 treatment-related effects were observed in both male and females rats at a dietary 
level of 4.5% (equivalent to a mean intake of 2600 mg/kg bw/day in males and 2800 mg/kg bw/day in 
females) and in female rats at a dietary level of 1.5% (equivalent to a mean intake of 1000 mg/kg 
bw/day). The no-observed-adverse-effect level (NOAEL) was considered by the Panel to be 300 
mg/kg bw/day, based on increased kidney weights in female rats at higher intake levels. 
Based on the use levels data calculated with the data provided by the applicant in 2009 for total dietary 
exposure (traditionally and non-traditionally smoked food), the margins of safety as compared to the 
NOAEL of 300 mg/kg bw/day in female rats derived from the 90-day toxicity study, amounted to 9 
and 14 for the intake estimates based on the upper use levels, and to 24 and 32 when normal use levels 
were considered. When assuming the use of Primary Product SmokeEz Enviro 23 in traditionally 
smoked products only, the margins of safety would amount to 21 and 36 based on the upper use levels 
and to 44 and 72 when normal use levels were considered. 
The CEF Panel considered that these margins of safety based on a 90-day toxicity study were 
inadequate, and that, in addition, data on reproduction and developmental toxicity as well as long term 
studies were absent.  The CEF Panel concluded that the margins of safety were insufficient and that 
the use of Primary Product SmokEz Enviro 23 at the proposed uses and use levels was of safety 
concern. 
The applicant has performed a new 90-day toxicity study in the rat and has submitted the results for 
evaluation by EFSA. As compared with the previous application, the applicant has modified the 
proposed normal and upper use levels of the Primary Product SmokEz Enviro 23 for the 18 food 
categories as outlined in Commission Regulation (EC) No 1565/2000. Accordingly EFSA has updated 
its former exposure assessment for SmokEz Enviro 23. 
The present opinion should be read in conjunction with the EFSA opinion of 2009, since this update 
only contains the new data provided by the applicant (chemical data, proposed normal and upper use 
levels and a 90-day toxicity study) and their evaluation by the CEF Panel. The other (chemical and 
toxicological) information required for the evaluation of smoke flavourings is available in the previous 
opinion and is still considered to apply to this product. 
The chemical data provided demonstrate that the test material used in the new 90-day toxicity study is 
representative of the Primary Product evaluated by EFSA (EFSA, 2009a). No additional data were 
provided on batch-to-batch variability and chemical stability during shelf life described for the 
Primary Product in the opinion of 2009. 
The Primary Product SmokEz  Enviro 23 has therefore been investigated in two 90-day subchronic 
toxicity studies in Wistar rats (10/sex/group). Animals were treated via the diet at concentrations up to 
4.4% in the feed in the first study and up to 2.25% in the feed in the second newly submitted study. 
Based on the findings in both 90-day studies the Panel derived a NOAEL for Primary Product SmokEz 
Enviro 23 of 598 mg/kg bw/day based on absolute and relative kidney weight changes in female rats.  SmokEz Enviro 23- 2012 Update
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In order to estimate dietary exposure to the Primary Product SmokEz Enviro 23, the CEF Panel used 
two different methodologies, developed by the Panel specifically for smoke flavourings. Dietary 
exposure estimates were calculated by assuming that the Primary Product SmokEz Enviro 23 is 
present at the upper use levels provided by the applicant for the 18 food categories as outlined in 
Commission Regulation (EC). 
Based on normal use levels, dietary exposure estimates from all sources were 7.9 and 9.6 mg/kg 
bw/day. Based on upper use levels these exposure estimates were 10.3 and 12.1 mg/kg bw/day. The 
two estimates based on normal use levels and the two estimates based on upper use levels were 
calculated according to the SMK-TAMDI and SMK-EPIC methodologies, respectively. 
Based on normal use levels, dietary exposure estimates from traditionally smoked foods only were 6.7 
and 9.2 mg/kg bw/day. Based on upper use levels these exposure estimates were 8.3 and 11.6 mg/kg 
bw/day. The two estimates based on normal use levels and the two estimates based on upper use levels 
were calculated according to the SMK-TAMDI and SMK-EPIC methodologies, respectively. 
The Panel re-calculated the margins of safety for the estimated exposure to Primary Product SmokEz 
Enviro 23 as the ratio between the NOAEL of 598 mg/kg bw/day, derived from two 90-day toxicity 
studies, and the estimated human dietary exposure, both expressed as mg/kg bw/day. 
Based on these data it is concluded that when assuming that the Primary Product SmokEz Enviro 23 is 
present at the normal use levels provided by the applicant for the 18 food categories, the margins of 
safety for the intake estimates as compared to the NOAEL of 598 mg/kg bw/day, identified in the 90-
day toxicity studies in rats, amount to 62 and 77. When assuming the use of Primary Product SmokEz 
Enviro 23 in traditionally smoked products only, the margins of safety would amount to 65 and 89. 
Based on these data it is concluded that when assuming that the Primary Product SmokEz Enviro 23 is 
present at the upper use levels provided by the applicant for the 18 food categories, the margins of 
safety for the intake estimates as compared to the NOAEL of 598 mg/kg bw/day, identified in the 90-
day toxicity studies in rats, amount to 49 and 58. When assuming the use of Primary Product SmokEz 
Enviro 23 in traditionally smoked products only, the margins of safety would amount to 52 and 72. 
However, given the fact that: 
i)  these margins of safety are based on 90-day toxicity studies, 
ii)  the absence of data on reproduction and developmental toxicity and 
iii)  the absence of long term studies, 
it is concluded that the uses and use levels of Primary Product SmokEz Enviro 23would require a 
larger margin of safety. Despite the increase in the margin of safety compared with the previous 
opinion due to the submission of an additional 90-day study and due to revised use levels provided by 
the applicant, the Panel concluded that the proposed use of the Primary Product SmokEz Enviro 23 at 
the uses and use levels specified is of safety concern. 
To decide whether despite the low margins of safety the use of Primary Product SmokEz Enviro 23 
might be approved for traditionally smoked products, at use levels specified, to replace smoking, is 
outside the remit of the Panel. 
The Panel did not anticipate that smoke flavourings would be used in food specifically designed for 
infants (0-12 months) and young children (12-36 months). Therefore the safety of use of Primary 
Product SmokEz Enviro 23 in such products was not assessed. SmokEz Enviro 23- 2012 Update
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION  
The European Parliament and Council Regulation (EC) No 2065/2003
4 provides the basis for securing 
a high level of protection for human health and the interests of consumers in relation to smoke 
flavourings used or intended for use in or on foods. It furthermore lays down a procedure for the 
evaluation and authorisation of primary smoke condensates and primary tar fractions and for the 
establishment of a list of primary smoke condensates and tar fractions to the exclusion of all others 
and their conditions of use.  
The European Food Safety Authority (EFSA) was asked to provide scientific opinion on the safety of 
the product SmokeEz Enviro 23. In its opinion adopted on 14 May 2009 EFSA stated that SmokeEz 
Enviro 23 is genotoxic in vitro, but not in vivo. The NOAEL derived from a 90-day study was 
considered by the Panel to be 300 mg/kg bw/day based on increased kidney weights in female rats at 
higher intake levels. EFSA concluded that the margin of safety is insufficient and that the use of 
Primary Product SmokeEz Enviro 23 at the proposed uses and use levels is of safety concern. 
 
Based on the conclusions drawn by EFSA the applicant has repeated a 90-day study and proposed new 
use levels. 
 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION  
The European Commission requests the European Food Safety Authority to carry out a safety 
assessment of the smoke flavouring Primary Product SmokEz Enviro 23 based on a new 90-day study, 
new use levels and new chemical data submitted by the applicant in accordance with Regulation (EC) 
No 2065/20034 of the European Parliament and the Council on smoke flavourings intended for use in 
or on foods. 
                                                      
 
4 Regulation (EC) No 2065/2003 of the European Parliament and of the Council of 10 November 2003 on smoke flavourings 
used or intended for use in or on foods. OJ L 309, 26.11.2003, p. 1-8. SmokEz Enviro 23- 2012 Update
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ASSESSMENT 
1.  Introduction 
The European Food Safety Autority (EFSA) has been asked by the European Commission (EC) to 
reconsider its safety assessment on the smoke flavouring Primary Product SmokEz Enviro 23 based on 
evaluation of a new 90-day toxicity study submitted by the applicant in accordance with Regulation 
(EC) No 2065/2003 of the European Parliament and the Council on smoke flavourings intended for 
use in or on foods. 
In the opinion published by EFSA in 2009 on the safety of smoke flavour Primary Product SmokEz 
Enviro 23 (EFSA, 2009a), the CEF Panel concluded  that the margins of safety calculated on the basis 
of a no-observed-adverse-effect-level (NOAEL) identified from a 90-day toxicity study, and on dietary 
exposure estimates (normal or upper use levels) from all food sources (18 food categories) as well as 
from only traditionally smoked foods, were insufficient and that the use of Primary Product SmokEz 
Enviro 23 at the proposed uses and use levels was of safety concern. 
The applicant has performed a new 90-day toxicity study and has submitted the results for evaluation 
by EFSA. The applicant has also proposed new use levels and new chemical data. 
The present opinion does not replace but complements the previous one published on 12 June 2009 
(EFSA, 2009a), and therefore both documents should be read in conjunction. This opinion only refers 
to the new information received from the applicant and to its impact on the safety assessment of the 
Primary Product SmokEz Enviro 23, i.e. chemical data on the material used in the new 90-day study, a 
new 90-day toxicity study and new information on use levels. The newly submitted data specifically 
include (i) the chemical analysis of the principal constituents and polycyclic aromatic hydrocarbons 
(PAHs) content of the material tested (demonstrating that this material is representative of the Primary 
Product previously assessed by EFSA), (ii) a new 90-day toxicity study and (iii) new proposed use 
levels. 
With respect to the other information submitted by the applicant prior to 2009 in accordance with the 
Guidance document (EFSA, 2005), the reader should refer to the opinion of 2009. The latter contains 
complementary chemical and toxicological data that still hold true for this Primary Product. 
1.1.  Summary of the previous opinion on the safety of the smoke flavouring Primary Product 
Smokez Enviro 23 (EFSA, 2009) 
The original summary taken from the opinion published by EFSA in 2009 on the safety of the smoke 
flavouring Primary Product SmokEz Enviro 23 (EFSA, 2009a) is given below. 
The Primary Product SmokEz Enviro 23 is obtained from mixed wood species. The average proportions 
reported by the applicant are as follows: maple (Acer saccharum) 47 % and oak (Quercus alba) 29 % 
as primary sources and hickory (Carya ovata), ash (Fraxinus amaricana), birch (Betula papyrifera and 
Betula alleghaniensis), wild black cherry (Prunus serotina), apple (Malus domestica), and beech 
(Fagus grandifolia) as secondary sources (2 %). 
The production of SmokEz Enviro 23 comprises the following steps: (i) drying of the hardwood 
sawdust, (ii) heating of the dried sawdust in a specified reactor, (iii) condensing of the released smoke, 
and (iv) separation of the aqueous part of the smoke condensate from non-aqueous phases by 
settlement and filtering. Essential parameters of the manufacturing process have been provided by the 
applicant. 
The water content of the Primary Product has been estimated as 67 wt. %. The amount of the volatile 
fraction determined by capillary gas chromatography amounted to 16 wt. % of the Primary Product. 14 
wt. % (corresponding to 88 % of the volatile fraction) were identified which is in compliance with 
Commission Regulation (EC) 627/2006 (EC, 2006). The total identified mass (18 wt. % of the Primary SmokEz Enviro 23- 2012 Update
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Product) corresponds to 54 % of the solvent-free fraction which is in compliance with Commission 
Regulation (EC) 627/2006 (EC, 2006).  
The contents of 12 of the 15 PAHs listed in Annex 2 of the EFSA guidance document (EFSA, 2005) have 
been determined in SmokEz Enviro 23 by an external accredited laboratory using the US-
Environmental Protection Agency (EPA) method 3510/8270-GC/MS. According to the applicant, for 5-
methylchrysene, cyclopenta[cd]pyrene and dibenzo[a,e]pyrene no analyses were performed because 
the calibration standards were not available at the time of the analysis. The levels of benzo[a]pyrene 
and benzo[a]anthracene are below their respective limits of 10 and 20 μg/kg given in Regulation (EC) 
No. 2065/2003 (EC, 2003). Although the concentrations of 5-methylchrysene, cyclopenta[cd]pyrene 
and dibenzo[a,e]pyrene, PAHs known to be carcinogenic, were not provided, the Panel concluded 
that based on the reported levels of other carcinogenic PAHs, the levels for 5-methylchrysene, 
cyclopenta[cd]pyrene and dibenzo[a,e]pyrene would be expected to be similarly low. 
The Panel considered the technical and analytical data provided acceptable to characterise the 
Primary Product and to demonstrate its batch-to-batch variability and stability. 
The reverse mutation test (Ames test) with bacteria was negative. The mouse lymphoma assay and the 
chromosome aberration assay in vitro both showed a positive response for the endpoint chromosome 
aberrations. The in vivo mouse micronucleus test and the in vivo UDS study were both negative.  
Overall, it is concluded that SmokEz Enviro 23 is genotoxic in vitro in the mouse lymphoma and the 
chromosome aberration assay, whereas two in vivo genotoxicity tests are negative and sufficient to 
eliminate the concerns over the in vitro genotoxicity. 
In the 90-day toxicity study with SmokEz Enviro 23 treatment-related effects were observed in both 
males and females at a dietary level of 4.5% (equivalent to a mean intake of 2600 mg/kg bw/day in 
males and 2800 mg/kg bw/day in females) and in females at a dietary level of 1.5% (equivalent to a 
mean intake of 1000 mg/kg bw/day). The no-observed-adverse-effect level (NOAEL) was considered 
by the Panel to be 300 mg/kg bw/day, based on increased kidney weights in female rats at higher 
intake levels.  
The applicant provided two data sets for use levels, one submitted originally in 2005, and the second in 
April 2009, after consulting with clients and seeking more detailed information on the actual use levels.  
Use levels of the Primary Product proposed by the applicant range between 1 g/kg food (ready-to-eat 
savouries, composite foods) and 5 g/kg food (dairy products, fish and meat). Dietary exposure to the 
primary product was not assessed by the applicant. 
In order to estimate dietary exposure to the Primary Product SmokeEz Enviro 23, the CEF Panel used 
two different methodologies, developed by the Panel specifically for smoke flavourings. Dietary 
exposure estimates were calculated by assuming that the Primary Product is present at the normal or 
upper use levels provided by the applicant for the 18 food categories as outlined in Commission 
Regulation (EC). 
Considering the initial data provided on use levels in 2005 the dietary exposure from all sources 
ranges from 23.9 to 26.0 mg/kg bw/day, when assuming that the Primary Product is present at the 
upper use levels, and from 10.9 to 13.0 mg/kg bw/day, when normal use levels are considered. 
Considering the updated information on use levels from 28 April 2009 the dietary exposure from all 
sources ranges from 20.8 to 33.3 mg/kg bw/day, when assuming that the Primary Product is present at 
the upper use levels, and from 8.7 to 12.5 mg/kg bw/day, when normal use levels are considered.  
The impact on exposure of using the Primary Product only in traditionally smoked food products was 
also assessed. SmokEz Enviro 23- 2012 Update
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Considering the initial data on use levels provided in 2005 the highest exposure estimates, resulting 
from the SMK-EPIC model, were 7.3 and 14.5 mg/kg bw/day when using normal and upper use levels, 
respectively. With the SMK-TAMDI model these figures were 4.2 and 8.3 mg/kg bw/day, respectively. 
Considering the updated information on use levels from 28 April 2009 the highest exposure estimates, 
resulting from the SMK-EPIC model, were 6.8 and 14.5 mg/kg bw/day when using normal and upper 
use levels, respectively. With the SMK-TAMDI model these figures were 4.2 and 8.3 mg/kg bw/day, 
respectively. 
Since the data on use levels originally provided in June 2005 have been updated by the applicant in 
April 2009, the Panel drew its conclusions based on the margins of safety calculated with these recent 
data. 
Based on the intake data calculated with the new data provided by the applicant on 28 April 2009 for 
total dietary exposure (traditionally and non-traditionally smoked food), the margins of safety as 
compared to the NOAEL of 300 mg/kg bw/day in female rats derived from the 90-day toxicity study 
amount to 9 and 14 for the intake estimates based on the upper use levels and to 24 and 34, when 
normal use levels are considered. 
When assuming the use of Primary Product SmokeEz Enviro 23 in traditionally smoked products only 
the margins of safety would amount to 21 and 36 based on the upper use levels and to 44 and 72 when 
normal use levels are considered.  
Considering that these margins of safety based on a 90-day toxicity study are inadequate, and that, in 
addition, data on reproduction and developmental toxicity, as well as long term studies are absent, it is 
concluded that the uses and use levels for the Primary Product in a wide range of product categories 
would require a larger margin of safety. The Panel concludes that the margins of safety are insufficient 
and that the use of the Primary Product SmokEz Enviro 23 at the proposed uses and use levels is of 
safety concern. 
It is outside the remit of the Panel to decide whether, despite the low margins of safety, the use of 
Primary Product SmokEz Enviro 23 might be approved for traditionally smoked products, at use levels 
specified, to replace smoking. 
2.  Technical data 
2.1 Identity of the Primary Product  
The batch of the Primary Product SmokEz Enviro 23 used for the additional 90-day oral toxicity study 
is R23-10120203. It was manufactured on October 12, 2010. 
2.1.1  Source materials for the Primary Product 
Table 1 shows the wood materials used to produce batch R23-10120203 of the Primary Product 
employed for the additional 90-day study and batch R23-05054280 employed for the 90-day study in 
the previous opinion (EFSA, 2009a). 
Table 1: Proportions of wood used to produce batch R23-10120203 of the Primary Product and batch 
R23-05054280 employed for the 90-day in the previous opinion (EFSA, 2009a). 
Lot  Maple (%)      
(Acer saccharum) 
Oak (%)  
(Quercus alba) 
Secondary Woods 
(%)
a) 
R23-10120203 62  38  0 
R23-05054280 49  41  10 
a) ash (Fraxinus americana), birch (Betula papyrifera and Betula alleghaniensis), wild black cherry (Prunus serotina) and 
beech (Fagus grandifolia) 
 SmokEz Enviro 23- 2012 Update
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The data for batch R23-10120203 are in accordance with the average proportions and ranges of wood 
materials (maple: 53%, min. 25% - max. 65%; oak: 45%, min. 20% - max. 75%; secondary woods: 
2%, min. 0% - max. 15%) previously reported by the applicant (EFSA, 2009a). 
2.1.2  Physical state of the Primary Product 
The specific gravity (1.075 g/ml) and the viscosity (2.2 cP at 25°C) are in sufficient agreement with 
average data (1.091 g/ml and 2.1 cP) provided in the previous opinion for the Primary Product 
SmokEz Enviro 23  (EFSA, 2009a). 
2.2.  Chemical description of the Primary Product 
2.2.1 Overall  characterisation 
Water functions as solvent of the Primary Product. The batch R23-10120203 had a water content of 
71.5 %. This is slightly higher than the value (67.0 %) previously reported for SmokEz Enviro 23 
(EFSA, 2009a).  
The applicant provided a list of 50 compounds screened for in batch R23-10120203 of the Primary 
Product by gas chromatography, gas chromatography/mass spectrometry and HPLC with UV 
detection. For 25 compounds quantitative values were presented, 23 compounds were present below 
their limits of detection (50 mg/kg), two were reported as not accessible via the applied technique. No 
analytical details and no data regarding the quantification procedure have been provided. 
The identified compounds amount to a total identified mass of 18.0 wt. % of batch R23-10120203. 
This corresponds to 63% of the solvent-free fraction and is thus in compliance with Commission 
regulation (EC) 627/2006 (EC, 2006). 
2.2.2  Chemical description of the Primary Product 
Data have been given on acids, phenols, carbonyls and solids. As shown in Table 2, the data for batch 
R23-10120203 are in sufficient agreement with those provided on batch R23-05054280 employed for 
the 90-day study in the previous opinion. They also meet the specifications provided for the Primary 
Product SmokEz Enviro 23 (EFSA, 2009a).  
Table 2: Major chemical parameters of the Primary Product SmokEz Enviro 23. 
 
  Batch 
R23-10120203 
Batch 
R23-05054280 
Specifications 
(EFSA, 2009) 
Total acidity (as acetic 
acid); wt.% 
6.1  5.9  6.0 – 7.0 
Carbonyls; wt.%  17.0  13.8  16.0 – 24.0 
Phenols (Smoke Flavor 
Compounds); mg/ml 
10.0 10.0  10.0  –  16.0 
Solids; °BRIX  
(g sucrose/100 g solution) 
26.4 25.6  not  available 
2.2.3  Identification and quantification of Primary Product constituents 
2.2.3.1 Principal  constituents 
A comparison of the contents of the 20 principal constituents reported for batch R23-05083338 of the 
Primary Product in the previous opinion (EFSA, 2009a) and those provided for batch R23-10120203 
used for the additional 90-day study is shown in Table 3.  SmokEz Enviro 23- 2012 Update
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Table 3: Principal constituents of the Primary Product SmokEz Enviro 23. 
 Constituent   Batch R23-05083338  
(g/kg) 
 Batch R23-10120203  
(g/kg) 
Acetic acid  39  55 
Hydroxyacetaldehyde 31  34 
Acetol (Hydroxypropanone)   19  14 
Glyceraldehyde 14  2.5 
Formic acid  7.2  16 
Methanol 4.8  5.3 
Formaldehyde 4.5  3.9 
Catechol (2-Hydroxyphenol)  2.4  -
a 
3-Buten-2-one  1.9    n.d.
b 
Propionic acid  1.8  2.7 
Methylglyoxal  1.5    n.d.
b 
Glyoxal 1.3  2.7 
2-Furaldehyde 1.3  1.2 
Cyclotene 1.2  1.1 
Acetaldehyde 1.2  0.73 
2,5-Dimethylphenol 1.0  n.d. 
Ethylene glycol  1.0  2.7 
Methyl acetate  1.0  1.2 
5-Hydroxymethylfurfural 1.0  1.3 
o-Cresol 0.8  0.3 
a according to the applicant, not accessible by the employed analytical method;  
b below the limit of detection: 50 mg/kg 
 
The Panel noted the marked difference in the contents of glyceraldehyde; in addition, four substances 
(catechol, 3-buten-2-one, methylglyoxal and 2,5-dimethylphenol ) reported as principal constituents in  
R23-05083338 were not detected in batch R23-10120203 .  
In the previous dossier GC-based data had been presented on the contents of selected constituents in 
13 batches of the Primary Product produced in 2004 and in 24 batches produced in 2005. As shown in 
Table 4, the contents of major (acetic acid, acetol, hydroxyacetaldehyde) as well as minor constituents 
(syringol, cyclotene, guaiacol) determined in the batch R23-10120203 were within these previously 
reported ranges. 
Table 4: Batch-to-batch variability of selected constituents in the Primary Product SmokEz Enviro 23. 
 
  batch        
R23-
05083338 
batch        
R23-
10120203 
13 batches    
(2004) 
24 batches         
(2005) 
Constituent  content   
(g/kg) 
content   
(g/kg) 
range    
(g/kg) 
mean    
(g/kg) 
range 
(g/kg) 
mean 
(g/kg) 
acetic acid  39  55  37 - 63  50  36 - 79  46 
acetol 
(hydroxypropanone) 
19  14  18 - 30  24  10 - 23  14 
hydroxyacetaldehyde  31  34  33 - 39  36  31 - 40  35 
syringol  0.8  1.1  0.6 – 1.0  0.8  0.4 – 1.7  0.6 
cyclotene  1.2  1.1  0.9 – 1.6  1.3  1.1 – 2.8  1.5 
guaiacol  0.3  0.4  0.2 – 0.5  0.3  0.2 – 0.7  0.3 SmokEz Enviro 23- 2012 Update
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2.2.3.2  Contents of Polycyclic Aromatic Hydrocarbons (PAHs) 
The contents of benzo(a)pyrene and benzo(a)anthracene in the test material SmokEz Enviro 23  (batch 
R23-10120203) were reported to be below the detections limits (0.05 and 0.1 ppb, respectively) of the 
employed methodology (HPLC with fluorescence detection). The contents of these two PAHs are thus 
below their respective limits of 10 and 20 µg/kg given in Regulation (EC) No. 2065/2003 (EC, 2003). 
No data have been provided on other PAHs. 
3.  Proposed use levels 
The revised use levels as proposed by the applicant for each of the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000
5  are summarized in Table 5. 
Table 5: Upper use levels of Primary Product SmokEz Enviro 23 in food categories as outlined in 
Commission Regulation (EC) No 1565/2000.  
 
 
Food categories  
Use  level 
(g/kg) 
Normal Upper
1  Dairy products, excluding products of category 2  0.2       0.2 
2  Fats and oils and fat emulsions (type water-in-oil)  0         0 
3  Edible ices, including sherbet and sorbet  0         0 
4.1  Processed fruits  0         0 
4.2  Processed vegetables (including mushrooms & fungi, roots & tubers,  
pulses & legumes) and nuts and seeds 
0         0 
5  Confectionery  0         0 
6  Cereals and cereal products, including flours & starches from  
roots & tubers, pulses & legumes, excluding bakery 
0         0 
7  Bakery wares  0         0 
8  Meat and meat products, including poultry and game  4.0       5.0 
9  Fish and fish products, including molluscs, crustaceans and echinoderms  2.0       3.0 
10  Egg and egg products  0         0 
11  Sweeteners, including honey  0         0 
                                                      
 
5 Commission Regulation (EC) No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96 of the European Parliament and of the Council. OJ L 
180, 19.07.2000, p. 8-16.  SmokEz Enviro 23- 2012 Update
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12  Salts, spices, soups, sauces, salads, protein products etc. 
12.1  Salt and salt substitutes 
12.2  Herbs, spices, seasonings, and condiments 
12.3  Vinegars 
12.4  Mustards 
12.5  Soups and broths 
12.6  Sauces and like products 
12.7.1  Salads (e.g. macaroni salas, potato salad) 
12.7.2  Sandwich spreads excluding cocoa and nut based spreads               
12.8  Yeast and like products 
12.9  Protein products 
12.10  Fermented soybean products 
2.5      
0  
 2.5      
0        
0        
0        
2.5      
0        
0        
0        
0        
0    
3 
0 
3 
0 
0 
0 
3 
0 
0 
0 
0 
0 
13  Foodstuffs intended for particular nutritional uses  0         0 
14.1  Non-alcoholic ("soft") beverages, excl. dairy products  0         0 
14.2  Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts  0         0 
15  Ready-to-eat savouries  2.5       4.0 
16  Composite foods (e.g. casseroles, meat pies, mincemeat) –  
foods that could not be placed in categories 1 - 15 
0         0 
 
4.  Dietary exposure assessment 
In order to estimate dietary exposure to the Primary Product, the CEF Panel used two different 
methodologies, namely the Smoke Theoretical Added Maximum Daily Intake (SMK-TAMDI) and the 
Smoke Flavouring European Prospective Investigation into Cancer and Nutrition model (SMK-EPIC). 
These methodologies were developed by the Panel specifically for smoke flavourings and are 
described in detail in the EFSA opinion on dietary exposure assessment methods for smoke flavouring 
Primary Products (EFSA, 2009b). 
As reported in Table 6, dietary exposures to SmokEz Enviro 23 were estimated by both the SMK-
TAMDI and SMK-EPIC methodologies, assuming that the Primary Product is present at normal and 
upper use levels provided by the applicant for the 18 food categories as outlined in Commission 
Regulation (EC). 
Estimated dietary exposure from all sources at normal use levels were 7.9 and 9.6 mg/kg bw/day, 
according to the SMK-TAMDI and SMK-EPIC methodologies, respectively.  
Estimated dietary exposure from all sources at upper use levels were 10.3 and 12.1 mg/kg bw/day, 
according to the SMK-TAMDI and SMK-EPIC methodologies, respectively. 
  SmokEz Enviro 23- 2012 Update
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Table 6: Summary of the dietary exposure estimates to the Primary Product SmokEz Enviro 23 
calculated on the basis of the normal and upper use levels. 
Methodologies 
Dietary 
exposure 
(mg/kg 
bw/day) 
Normal    
Upper 
SMK-TAMDI 
Traditionally smoked food  6.7  8.3 
Other foods not traditionally smoked  1.3  2.0 
Beverages (alcoholic or non-alcoholic)  0.0  0.0 
Total dietary exposure  7.9  10.3 
SMK-EPIC 
Traditionally smoked food  9.2  11.6 
Other foods not traditionally smoked  0.4  0.5 
Beverages (alcoholic or non-alcoholic)  0.0  0.0 
Total dietary exposure  9.6  12.1 
 
5.  Toxicology 
5.1  Identity of the test material 
The batch used for the newly submitted 90-day rat toxicity study is 10120203 and was manufactured 
on October 12, 2010. 
5.2  90-day dietary toxicity studies 
In the previous opinion on Primary Product SmokEz Enviro R23, already the result of a 90-day dietary 
toxicity study was available. From this study a NOAEL of 300 mg/kg bw/day could be derived (see 
section 1.1). For the present update a second 90-day dietary toxicity study has been submitted. In order 
to facilitate the comparison of the results from the two studies, the evaluation of the first 90-day study 
is quoted verbatim from the original opinion on this Primary Product. 
5.2.1  First 90-day dietary toxicity study (text taken verbatim from the EFSA 2009 opinion) 
A comprehensive 90-day subchronic toxicity study was conducted according to GLP guidelines on 
SmokEz Enviro 23 (TNO, 2005a).  
Subchronic toxicity was assessed by dietary administration to groups of 10 animals per sex for 90 
days at 0, 0.45, 1.5 and 4.5% (equivalent to overall mean intakes of 270, 900 and 2600 mg/kg bw/day 
in males and 300, 900 and 2800 mg/kg bw/day in females). Two smoke condensates (SmokEz C-10 and 
SmokEz Enviro 23) were tested at each concentration in the study but only a single control (0%) 
group of 10 animals per sex was used. The results described below are for SmokEz Enviro 23.  
No clinical signs were reported on observation (twice daily on working days, daily on weekends and 
holidays) or in motor activity assessment (clinical observations weekly until week 12, functional 
observational battery and motor activity assessment in week 13), thus SmokEz Enviro 23 showed no 
evidence of a neurotoxic potential. Ophthalmoscopic examinations were undertaken prior to dosing 
and final week in the control and high dose groups only, no adverse findings were observed.  
Body weight decreases were observed in both sexes in the high-dose group and at some times points 
(days 42, 56 and 91) for mid-dose females; these body weight changes were accompanied by 
decreased food consumption but no changes in food conversion efficiency. There was also decreased 
water consumption in high dose males. SmokEz Enviro 23- 2012 Update
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In haematological testing, the mean corpuscular volume (MCV) increased in both sexes and mean 
corpuscular haemoglobin (MCH) in females at 4.5% SmokeEz Enviro 23, the thrombocyte count 
increased at 4.5% SmokeEz Enviro 23. The number of eosinophils decreased in males fed SmokEz 
Enviro 23 but these were considered incidental effects since these changes were marginal, not dose-
related and not associated with significant effects on the relative distribution of eosinophils. 
The following changes in clinical chemistry were observed: 
•  Decreases in aspartate aminotransferase (serum glutamic-oxaloacetic transaminase) in both 
sexes at 4.5% SmokeEz Enviro 23 
•  Decreases in alkaline phosphatase in females at 1.5 and 4.5% SmokeEz Enviro 23 (also 
decreased in mid but not high dose males considered fortuitous) 
•  Increases in albumin in males at 4.5% SmokeEz Enviro 23 
•  Increases in cholesterol and phospholipids in females at 4.5% SmokeEz Enviro 23 
•  Increases in triglycerides in females at 4.5% SmokeEz Enviro 23 
•  Decreases in creatinine in both sexes at 4.5% SmokeEz Enviro 23 
•  Urinalysis showed increased urinary volume and decreased density in females at 4.5% 
There were increases in relative kidney weight of 9% and 11% in the mid (1.5%) and high (4.5%) dose 
females and 1% in high dose males (4.5 %) for SmokEz Enviro 23. There were increases in relative 
liver weight of 8% and 16% in the mid (1.5%) and high (4.5%) dose females and 4% in high (4.5%) 
dose males on SmokEz Enviro 23. However there was no treatment related macroscopic or 
microscopic (histopathological) finding. In the opinion of the Panel, the no-observed-adverse-effect 
level (NOAEL) in this study was therefore 290 mg/kg bw/day (0.45% in the diet) in female rats and 
900 mg/kg bw/day in males based on kidney weights. 
The no-observed-adverse-effect level (NOAEL) was considered by the Panel to be 300 mg/kg bw/ day, 
based on the findings on the kidney weight and body weight in female rats. 
5.2.2   Newly submitted 90-day dietary toxicity study in rats (Grósz, 2012) 
A comprehensive 90-day subchronic toxicity study was conducted with SmokEz Enviro 23, batch 
number 10120203, according to OECD guideline 408 and in compliance with GLP (Grósz, 2012). 
 
The test material was administered to groups of 10 Wistar rats per sex at 0, 0.9, 1.35, 1.8 and 2.25% 
(w/w) in the diet. The intake of study substance per kg body weight per day was calculated from the 
nominal dietary concentration, the food consumption and the mean body weights of the animals during 
the study and was equal to overall mean intakes of 0, 530, 811, 1083 and 1367 mg/kg bw/day in males 
and 0, 598, 952, 1266 and 1562 mg/kg bw/day in females. 2,6-Dimethoxyphenol (2,6-DMP or 
syringol) ; present at relatively high levels in the test substance) was used as a tracer compound in the 
diets to calculate the actual content of SmokEz Enviro 23. The actual concentrations of the test 
material in the feed were on average 0, 124, 123, 125 or 127% of the nominal feed concentrations. The 
stability of the test material in the diets was confirmed by investigation of the 2,6-DMP contents in 
fresh and frozen diet samples (up to two months of storage). 
 
There were no clinical signs of toxicity during the study, and none of the rats died. Ophthalmoscopic 
examination did not reveal any treatment-related effects. There were statistically significant variations 
observed in the landing foot splay test in the SmokeEz Enviro 23 treated males at 1.35% and 2.25% 
dose, but no dose response relationship was observed. Also statistical significant and weakly dose-SmokEz Enviro 23- 2012 Update
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related differences in the mean grip strength were noted of the hind limbs, with a reduction in all 
treated males and an increase in the two top doses in females.  
 
Male body weights at the end of the study were slightly lower in the exposed groups as compared to 
the control animals (-1%, 0%, -1% and -4% in the 0.9, 1.35, 1.8 and 2.25% dose groups, respectively). 
No treatment related effect on the body weight was observed in the female animals. There was no 
effect on feed intake and on feed conversion. Water consumption was not monitored. 
 
There was a statistical change in the mean platelet volume (MPV) in both male (8.1, 11.1, 11.8, 10.4 
and 10.5 fL in the 0, 0.9, 1.35, 1.8, 2.25% dose groups respectively) and female 8.5, 10.8, 11.0, 9.1 
and 9.9 fL in the 0, 0.9, 1.35, 1.8, 2.25% dose groups respectively) rats, but no dose-response were 
observed. A statistical and weakly dose-related decrease in the prothrombin time (PT) was observed in 
all doses in male (24.4, 23.5, 23.5, 22.2, 21.8 s in the 0, 0.9, 1.35, 1.8 and 2.25% dose groups, 
respectively) and in the two top doses in female (23.1, 22.6, 22.7, 21, 21.3 s in the 0, 0.9, 1.35, 1.8 and 
2.25% dose groups, respectively) rats. Sporadic significant changes in the mean cell volume (MCV), 
haematocrit (Hct), monocytes and mean cell haemoglobin concentration was observed, but without 
any dose response relationship. 
 
A clear dose-related and statistically significant decrease in plasma creatinine concentrations in males 
and females was observed at 0.9% and above (Table 7).  
 
Table 7: Changes in blood biochemistry parameters and organ weights. 
 
  Dose groups (% w/w) 
% in feed  0  0.9  1.35  1.8  2.25 
Biochemistry 
Creatinine (μM) males, U 44.8  37.5** 35.8** 31.8** 31.7** 
Creatinine (μM) females, DN 57.1  44.9** 45.2** 38.3** 43.6** 
Organ weights 
Absolute kidney weight males (g) 3.0  2.9  3.1  3.1  3.1 
Relative kidney weight males (%) 0.537  0.531  0.555  0.549  0.583 
Absolute kidney weight females (g), 
DN
1.80 1.75 1.91  1.97**  1.94* 
Relative kidney weight females (%), 
DN
0.609 0.589 0.626  0.668**  0.665** 
Relative kidney weight females (% 
difference), DN
- -3.3 
 
2.8 
 
9.7** 
 
9.2** 
 
*  Statistical significance P<0.05 
** Statistical significance P<0.01 
DN = Duncan’s multiple range test, U = Mann-Whitney U-test 
 
No other consistent treatment-related changes in clinical chemistry parameters (including plasma 
sodium concentrations, plasma phosphate levels, total protein, albumin, cholesterol, or lipoproteins) 
were observed in either sex. No changes were reported in urinary parameters (volume, pH, specific 
gravity).  
 
No toxicologically relevant macroscopic or microscopic organ changes were observed. In the females, 
a weakly dose-related increase in the absolute kidney weight and relative (to body weight) kidney 
weights were observed, where a statistical significance was reached in the 1.8 and 2.25% treatment 
groups. No change in relative to brain- kidney weights were observed. In the males also a weakly 
dose-related increase in relative kidney weight was observed, but here statistical significance was not 
reached. Liver weights and thyroid weights were unaffected in either sex. For quantitative information 
on the organ weight changes see table 7. 
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The study author noted the following: 
 
•  A weak dose-response related change in the mean grip strength was observed, but the effects 
were regarded as incidental because of high variability in individual values, they were not 
accompanied by any clinical signs and the data were within the historical control data. 
However, the historical control data were not given. 
•  The overall body weight gain of male rats at the highest dose tested was slightly lower 
compare to control rats. The causative role of the test item can not be excluded, however, the 
effect was small in magnitude. 
•  The haematological changes were in the normal ranges for the various parameters studies and 
no dose or gender-related changes were observed. 
•  Although test item-related effects on creatinine cannot be excluded, the parameter values 
remained within the physiological ranges and correlated findings in other parameters were 
absent. The variations observed were therefore not considered to reflect an adverse effect. 
•  As the increase in absolute and relative kidney weight in female rats were within the normal 
range, the variations had low magnitude and were not correlated with pathological findings, 
they were not considered to reflect an adverse effect of SmokeEz Enviro 23. 
 
For these reasons the study authors concluded that there were no toxicologically relevant effects in the 
exposed animals and derived a NOAEL of 2.25% equivalent to 1367 mg/kg bw/day in males from this 
study.  
 
The Panel noted that for none of the effects discussed by the study author, historical control values 
were provided in the report. The changes observed in the landing foot splay test and the mean grip 
strength show a lack of or only weak dose-response relationship, and the effect on the mean grip 
strength were opposite in males and females. Where changes were observed in biochemical and 
haematological parameters, these were in general very small, and do not seem to have any 
physiological relevance. However, similar to the previous study there were effects on body weight 
gain and changes in relative kidney weight, blood biochemistry parameters (i.e. creatinine), which 
might be indicative of kidney functional changes. Therefore the Panel concluded that these changes 
are treatment–related.  
 
Deriving a NOAEL using results from both 90-day studies. 
The Panel noted that in the first 90-day study (see section 5.2.1) similar changes in body weight and 
kidney-related parameters were observed in female rats. This new study is very comparable to the 
previous 90-day study, also regarding the severity of the observed toxicological effects in females. No 
statistically significant difference in organ weight was observed in males. To derive a NOAEL for 
Primary Product SmokEz Enviro 23, results on relative increase in kidney weight in females are 
combined from both studies. The combined data are presented in table 8. 
Table 8: Changes in relative kidney weight in females (both 90-day studies). 
 
  dose groups (mg/kg bw/day) via feed 
0 300 598 900 952 1266
  1562
  2800
Relative kidney weight 
females (% difference) in 
the first 90-day study 
(TNO 2005a) 
- 0 -  9*  - - -  11* 
Relative kidney weight 
females (% difference) in 
the second 90-day study 
(Grósz, 2012) 
-  - -3.3 - 2.8  9.7*  9.2* - 
* Statistical significance SmokEz Enviro 23- 2012 Update
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The Panel concluded that the overall NOAEL for the Primary Product SmokEz Enviro 23 is 598 
mg/kg bw/day from the second study. Above this level of exposure in both 90-day studies of increase 
in relative kidney weight in female rats were observed. 
 
6.  Discussion 
The present opinion describes the results of the evaluation of new data (new use levels, chemical data 
and a new sub-chronic toxicity study) provided by the applicant on Primary Product. The other 
information required for the evaluation of the Primary Product SmokEz Enviro 23, in accordance with 
the Guidance document (EFSA, 2005), is available in the previous opinion published on 14 June 2009 
(EFSA, 2009a). 
 
The Panel noted some inconsistencies between the principal constituents previously described in batch 
R23-05083338 and those reported in batch R23-10120203. However, taking into account the ranges 
previously reported for selected constituents in a total of 37 batches and the additional technical 
information provided, the Panel considered the data acceptable to demonstrate that the material tested 
in the additional 90-day study (SmokEz Enviro 23, batch  R23-10120203) is representative of the 
Primary Product evaluated by EFSA in 2009 (EFSA, 2009a). 
The Primary Product SmokEz Enviro 23 has therefore been investigated in two 90-day subchronic 
toxicity studies in Wistar rats (10/sex/group). Animals were treated via the diet at concentrations up to 
4.4% in the feed in the first study and up to 2.25 % in the feed in the second newly submitted study. 
Based on the findings in both 90-day studies the Panel derived a NOAEL for Primary Product SmokEz 
Enviro 23 of 598 mg/kg bw/day based on the absolute and relative kidney weight changes in female 
rats.  
In order to estimate dietary exposure to the Primary Product SmokEz Enviro 23, the CEF Panel used 
two different methodologies, developed by the Panel specifically for smoke flavourings. Dietary 
exposure estimates were calculated by assuming that the Primary Product SmokEz Enviro 23 is 
present at the upper use levels provided by the applicant for the 18 food categories as outlined in 
Commission Regulation (EC). 
Based on normal use levels, dietary exposure estimates from all sources were 7.9 or 9.6 mg/kg 
bw/day. Based on upper use levels these exposure estimates were 10.3 and 12.1 mg/kg bw/day. The 
two estimates based on normal use levels and the two estimates based on upper use levels were 
calculated according to the SMK-TAMDI and SMK-EPIC methodologies, respectively. 
Based on normal use levels, dietary exposure estimates from traditionally smoked foods only were 6.7 
or 9.2 mg/kg bw/day. Based on upper use levels these exposure estimates were 8.3 and 11.6 mg/kg 
bw/day. The two estimates based on normal use levels and the two estimates based on upper use levels 
were calculated according to the SMK-TAMDI and SMK-EPIC methodologies, respectively. 
 
The Panel re-calculated the margins of safety for the estimated exposure to Primary Product SmokEz 
Enviro 23 as the ratio between the NOAEL of 598 mg/kg bw/d, derived from two 90-day toxicity 
studies, and the estimated human dietary exposure, both expressed as mg/kg bw/day (Table 9). 
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Table 9: Margins of safety calculated on the basis of the upper use levels. 
 Dietary  exposure   
(mg/kg bw/day) 
NOAEL
(mg/kg 
bw/day) 
Margins of safety 
 Normal  use 
levels 
Upper use 
levels 
 Normal  use 
levels 
Upper use levels
Total dietary 
exposure 
7.9
(a)
 / 9.6
(b)
 10.3
(a)
 / 12.1
(b)
  598  77
(a)
 / 62
(b)
 58
(a)
 / 49
(b)
 
Traditionally 
smoked food 
6.7
(a)
 / 9.2
(b)
 8.3
(a)
 / 11.6
(b)
  598  89
(a)
 / 65
(b)
 72
(a)
 / 52
(b)
 
(a): if dietary exposure is estimated on the basis of the SMOKE-TAMDI model 
(b): if dietary exposure is estimated on the basis of the SMOKE-EPIC model 
 
Based on these data it is concluded that when assuming that the Primary Product SmokEz Enviro 23 is 
present at the normal use levels provided by the applicant for the 18 food categories, the margins of 
safety for the intake estimates as compared to the NOAEL of 598 mg/kg bw/day, identified in the 90-
day toxicity studies in rats, amount to 62 and 77 (Table 9). When assuming the use of Primary Product 
SmokEz Environ 23 in traditionally smoked products only, the margins of safety would amount to 65 
and 89 (Table 9). 
 
Based on these data it is concluded that when assuming that the Primary Product SmokEz Enviro 23 is 
present at the upper use levels provided by the applicant for the 18 food categories, the margins of 
safety for the intake estimates as compared to the NOAEL of 598 mg/kg bw/day, identified in the 90-
day toxicity studies in rats, amount to 49 and 58 (Table 9). When assuming the use of Primary Product 
SmokEz Enviro 23 in traditionally smoked products only, the margins of safety would amount to 52 
and 72 (Table 9). 
 
However, given the fact that: 
i)  these margins of safety are based on 90-day toxicity studies, 
ii)  the absence of data on reproduction and developmental toxicity and 
iii)  the absence of long term studies, 
it is concluded that the uses and use levels of Primary Product SmokEz Enviro 23 would require a 
larger margin of safety. Despite the increase in the margin of safety compared with the previous 
opinion due to the submission of an additional 90-day study and due to revised use levels provided by 
the applicant, the Panel concluded that the proposed use of the Primary Product SmokEz Enviro 23 at 
the uses and use levels specified is of safety concern. 
 
The Panel did not anticipate that smoke flavourings would be used in food specifically designed for 
infants (0-12 months) and young children (12-36 months). Therefore the safety of use of Primary 
Product SmokEz Enviro 23 in such products was not assessed. 
CONCLUSIONS AND RECOMMENDATIONS 
The European Food Safety Authority (EFSA) has been asked by the European Commission (EC) to 
reconsider its safety assessment of the smoke flavouring Primary Product SmokEz Enviro 23 based on 
new data (new use levels, chemical data and a new sub-chronic toxicity study) provided by the 
applicant on the Primary Product SmokEz Enviro 23. The other information required for the 
evaluation of the Primary Product SmokEz Enviro 23, in accordance with the Guidance document 
(EFSA, 2005), is available in the previous opinion adopted on 14 May 2009 (EFSA, 2009a). 
 
Despite some differences between the principal constituents reported in the previous opinion (EFSA, 
2009a) and those provided for the batch R23-10120203, the Panel considered the submitted technical SmokEz Enviro 23- 2012 Update
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data as acceptable to demonstrate that the material tested in the new 90-day study is representative of 
the Primary Product SmokEz-Enviro 23. 
When considering the new use levels provided by the applicant and assuming application of SmokEz 
Enviro 23 in foods from all indicated food categories, the resulting margins of safety were 49 or 58 
(upper use levels) and 62 and 77 (normal use levels) depending on the exposure scenario used. When 
assuming the use of Primary Product SmokEz Enviro 23 in traditionally smoked products only, the 
margins of safety would amount to 52 and 72 (upper use levels) and 65 and 89 (normal use levels). 
Given i) the fact that these margins of safety are based on a 90-day toxicity study, ii) the absence of 
data on reproduction and developmental toxicity and iii) the absence of long term studies, it is 
concluded that the uses and use levels of Primary Product SmokEz Enviro 23 would require a larger 
margin of safety. Despite the increase in the margin of safety compared with the previous opinion due 
to the submission of an additional 90-day toxicity study and due to revised use levels provided by the 
applicant, the Panel concluded that the proposed use of the Primary Product SmokEz Enviro 23 at the 
uses and use levels specified is of safety concern. 
 
To decide whether despite the low margins of safety the use of Primary Product SmokEz Enviro 23 
might be approved for traditionally smoked products, at use levels specified, to replace smoking, is 
outside the remit of the Panel. 
 
The Panel did not anticipate that smoke flavourings would be used in food specifically designed for 
infants (0-12 months) and young children (12-36 months). Therefore the safety of use of Primary 
Product SmokEz Enviro 23 in such products was not assessed. 
 
DOCUMENTATION PROVIDED TO EFSA 
1. Additional dietary 90-day sub-chronic toxicity study in Wistar rats (Grósz, 2012) with smoke 
flavouring Primary Product SmokEz Enviro 23, July 2012. 
 
2. Revised maximum use levels for SmokEz Enviro 23. 
 
3. Identification and characterization of SmokEZ Enviro 23 according to Regulation 627/2006 
and evidence that the SmokEz Enviro 23tested in the new 90-day assay is representative of the 
commercial product. 
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GLOSSARY / ABBREVIATIONS 
 
bw   body  weight 
CEF    Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
  A i d s  
EC   European  Commission 
EFSA    European Food Safety Authority 
EPIC    European Prospective Investigation into Cancer and Nutrition  
GC/MS   Gas Chromatography/Mass Spectrometry 
GLP    Good Laboratory Practice 
NOAEL No-Observed-Adverse-Effect  Level 
OECD    Organisation for Economic Cooperation and Development 
PAHs    Polycyclic Aromatic Hydrocarbons  
SMK-EPIC  Smoke flavouring EPIC model 
SMK-TAMDI  Smoke Theoretical Added Maximum Daily Intake  
TAMDI  Theoretical Added Maximum Daily Intake 
 
 
 